Metraipolis › archive › dc_0345f2da9d12

IL-4Rα antagonist (Stapokibart) in refractory palmoplantar pustulosis: a case report and literature review of Th2-targeted therapies — Europe PMC PMID:42661770

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42661770
DOI
10.3389/fimmu.2026.1851685
License (as archived)
solo-consultazione
Archived
2026-10-16T16:35:44.922Z
SHA-256 of the archived text
9ef1b67902df631729f778dd8d4fca8e224ba038100d401eb9c1a921873aa9c9
Stable URL of this page
https://metraipolis.com/documento/dc_0345f2da9d12

How to cite

IL-4Rα antagonist (Stapokibart) in refractory palmoplantar pustulosis: a case report and literature review of Th2-targeted therapies — Europe PMC PMID:42661770 — Europe PMC (en), https://europepmc.org/article/MED/42661770 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0345f2da9d12 (Metraipolis archive dc_0345f2da9d12, sha256 9ef1b67902df631729f778dd8d4fca8e224ba038100d401eb9c1a921873aa9c9)
BibTeX
@misc{dc0345f2da9d12,
  title = {IL-4Rα antagonist (Stapokibart) in refractory palmoplantar pustulosis: a case report and literature review of Th2-targeted therapies — Europe PMC PMID:42661770},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42661770},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0345f2da9d12; sha256 9ef1b67902df631729f778dd8d4fca8e224ba038100d401eb9c1a921873aa9c9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42661770. Agents can read the archived copy with the MCP tool read_document.